You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

List of Excipients in API DIVALPROEX SODIUM


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing DIVALPROEX SODIUM

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
AbbVie Inc DEPAKOTE divalproex sodium 0074-3826 CELLULOSE, MICROCRYSTALLINE
AbbVie Inc DEPAKOTE divalproex sodium 0074-3826 FD&C BLUE NO. 1
AbbVie Inc DEPAKOTE divalproex sodium 0074-3826 HYPROMELLOSE
AbbVie Inc DEPAKOTE divalproex sodium 0074-3826 LACTOSE
AbbVie Inc DEPAKOTE divalproex sodium 0074-3826 POLYETHYLENE GLYCOL
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing DIVALPROEX SODIUM

Company Ingredient NDC Excipient
Mylan Pharmaceuticals Inc divalproex sodium 0378-0472 AMMONIA
Mylan Pharmaceuticals Inc divalproex sodium 0378-0472 CELLULOSE, MICROCRYSTALLINE
Mylan Pharmaceuticals Inc divalproex sodium 0378-0472 DIBUTYL SEBACATE
Mylan Pharmaceuticals Inc divalproex sodium 0378-0472 ETHYLCELLULOSE
Mylan Pharmaceuticals Inc divalproex sodium 0378-0472 HYDROXYETHYL CELLULOSE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for DIVALPROEX SODIUM

Excipient focus: 2-(3-OXAZOLIDINYL)ETHYL METHACRYLATE

Excipient focus: ACETONE

Excipient focus: ALCOHOL

Excipient focus: AMMONIA

Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Excipient focus: BROWN IRON OXIDE

Excipient focus: BUTYL ALCOHOL

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CI 77499

Excipient focus: CI 77891

Excipient focus: COLLOIDAL SILICON DIOXIDE

Excipient focus: COPOVIDONE

Excipient focus: COPOVIDONE K25-31

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: D&C RED NO. 27

Excipient focus: D&C RED NO. 28

Excipient focus: D&C RED NO. 30

Excipient focus: DIACETYLATED MONOGLYCERIDES

Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE

Excipient focus: DIBUTYL SEBACATE

Excipient focus: DIETHYL PHTHALATE

Excipient focus: DIMETHICONE

Excipient focus: ETHYL ACRYLATE

Excipient focus: ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER

Excipient focus: ETHYLCELLULOSE

Excipient focus: ETHYLCELLULOSES

Excipient focus: FD&C BLUE NO. 1

DIVALPROEX SODIUM drug variants not containing FD&C BLUE NO. 1

Company Ingredient NDC
Mylan Pharmaceuticals Inc divalproex sodium 0378-0472
NCS HealthCare of KY Inc dba Vangard Labs divalproex sodium 0615-7531
NCS HealthCare of KY Inc dba Vangard Labs divalproex sodium 0615-7848
NCS HealthCare of KY Inc dba Vangard Labs divalproex sodium 0615-7849
NCS HealthCare of KY Inc dba Vangard Labs divalproex sodium 0615-7956
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 5

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

DIVALPROEX SODIUM drug variants containing FERROSOFERRIC OXIDE

Company Ingredient NDC
NCS HealthCare of KY Inc dba Vangard Labs divalproex sodium 0615-7956
NCS HealthCare of KY LLC dba Vangard Labs divalproex sodium 0615-8237
NCS HealthCare of KY Inc dba Vangard Labs divalproex sodium 0615-8330
NCS HealthCare of KY LLC dba Vangard Labs divalproex sodium 0615-8376
Major Pharmaceuticals divalproex sodium 0904-6364
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: GELATIN

Excipient focus: GLYCERYL BEHENATE

Excipient focus: GLYCERYL BEHENATE/EICOSADIOATE

Excipient focus: GLYCERYL DIBEHENATE

Excipient focus: HYDROGENATED COTTONSEED OIL

Excipient focus: HYDROXYETHYL CELLULOSE

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED

Excipient focus: HYDROXYPROPYL METHYLCELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2208

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSE PHTHALATE

Excipient focus: HYPROMELLOSES

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

DIVALPROEX SODIUM drug variants containing LACTOSE MONOHYDRATE

Company Ingredient NDC
NCS HealthCare of KY Inc dba Vangard Labs divalproex sodium 0615-7956
NCS HealthCare of KY Inc dba Vangard Labs divalproex sodium 0615-8329
NCS HealthCare of KY Inc dba Vangard Labs divalproex sodium 0615-8330
NCS HealthCare of KY LLC dba Vangard Labs divalproex sodium 0615-8376
Major Pharmaceuticals divalproex sodium 0904-6363
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: LECITHIN, SOYBEAN

Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MANNITOL

Excipient focus: METHACRYLIC ACID

Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER

Excipient focus: METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER

Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER

Excipient focus: METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER

Excipient focus: METHYLENE CHLORIDE

Excipient focus: MICROCRYSTALLINE CELLULOSE 101

Excipient focus: MICROCRYSTALLINE CELLULOSE 102

Excipient focus: MICROCRYSTALLINE CELLULOSE 112

Excipient focus: N-BUTYL ALCOHOL

Excipient focus: OLEIC ACID

Excipient focus: POLYDEXTROSE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 3000

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POTASSIUM HYDROXIDE

Excipient focus: POTASSIUM SORBATE

Excipient focus: POVIDONE

Excipient focus: POVIDONE K12

Excipient focus: POVIDONE K29/32

Excipient focus: POVIDONE K30

Excipient focus: POVIDONES

Excipient focus: PROPYL GALLATE

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PVP

Excipient focus: RAW SUGAR

Excipient focus: RED 40

Excipient focus: SHELLAC

Excipient focus: SILICA

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM BICARBONATE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

DIVALPROEX SODIUM drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO

Company Ingredient NDC
NCS HealthCare of KY Inc dba Vangard Labs divalproex sodium 0615-7848
NCS HealthCare of KY Inc dba Vangard Labs divalproex sodium 0615-7849
Zydus Lifesciences Limited divalproex sodium 65841-634
Contract Pharmacy Services-PA divalproex sodium 67046-137
Zydus Pharmaceuticals (USA) Inc divalproex sodium 68382-031
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: SOYBEAN LECITHIN

Excipient focus: STARCH, CORN

Excipient focus: STARCH, PREGELATINIZED CORN

Excipient focus: STEARIC ACID

Excipient focus: SUCROSE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: TRIETHYL CITRATE

Excipient focus: VANILLIN

Excipient focus: WATER

Excipient focus: XANTHAN GUM

Excipient focus: ZEA MAYS

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links